Herpes virus infections

Clinical information

The family of herpesviruses encompasses more than 100 different virus types, eight of which can cause infections in humans. These so-called human herpesviruses encompass herpes simplex virus of type 1 and 2 (HSV-1 and -2), varicella zoster virus (VZV), Epstein-Barr virus (EBV), cytomegalovirus (CMV), human herpesviruses 6 and 7 (HHV-6 and -7) as well as human herpesvirus 8 (HHV-8), which is associated with Kaposi sarcoma. Despite great structural similarities of the different pathogens, herpesvirus infection can cause very different diseases, e.g. cold sores or genital herpes, chickenpox, shingles, kissing disease or different cancers. During pregnancy, especially primary infection with particular herpesviruses may lead to severe damage or even loss of the child. There is currently only a vaccine against VZV. After primary infection, which often proceeds asymptomatically, herpesviruses persist life-long in the body in a latent state and may become reactivated at a later time point, e.g. due to a weakened immune system, and (again) cause symptoms.

Diagnostics

Laboratory diagnostics of herpesviruses is based on direct or indirect detection methods. Direct methods, which are especially relevant for diagnostics of acute infections or in immunosuppressed persons include, e.g. virus culture or PCR-based tests, in which viral nucleic acids are detected. Blister liquid, skin or mucosal smears, blood, CSF or broncoalveolar lavage fluid is used as sample material. If the herpesvirus specific antibody is detected in patient serum, plasma or CSF, this is considered as indirect pathogen detection. The antibody detection not only allows conclusions to be drawn on which virus is present in the patient, but can also contribute to the differentiation of primary and recurrent infections. EUROIMMUN offers a broad spectrum of products for the detection of herpesvirus infections, including both antibody detection and direct detection methods.

Selected Products

MethodParameterSubstrateSpecies 
PCREURORealTime HSV-1/2Details
EUROArrayEUROArray HSV1/2 VZVDetails
ChLIAControl set
Herpes simplex virus 1 (HSV-1)
Details
WESTERNBLOTantibodies against Herpes simplex virus (HSV)
IgG positive control
Details
ChLIAHerpes simplex virus 1
(HSV-1)
Details
ELISACSQ pair of controls
anti-HSV-1/2 Pool (IgG)
Details
WESTERNBLOTEUROLINE-WB
Herpes simplex virus 1 (HSV-1)
plus HSV-2 type-specific
glycoprotein G2
Westernblot
Details
ELISAHerpes simplex virus
(HSV-1/2 Pool)
antigen-coated
microplate wells
Details
ELISAHerpes simplex virus
(HSV-1/2 Pool)
antibody determination in CSF
antigen-coated
microplate wells
Details
ELISAHerpes simplex virus
(HSV-1/2 Pool)
incl. IgG/RF absorbent
antigen-coated
microplate wells
Details
ELISAHerpes simplex virus 1
(HSV-1)
antigen-coated
microplate wells
Details
ChLIAHerpes simplex virus 2 (HSV-2)Details
ChLIAControl set
Herpes simplex virus 2 (HSV-2)
Details
ELISAHerpes simplex virus 2
(HSV-2)
antigen-coated
microplate wells
Details
IIFTHHV-6infected cellsEU 30Details
IIFTHHV-6 EUROPatterninfected cellsEU 30Details
ELISACytomegalovirus
(CMV)
antigen-coated
microplate wells
Details
ELISACytomegalovirus (CMV)
incl. IgG/RF absorbent
antigen-coated
microplate wells
Details
ELISACytomegalovirus (CMV)
avidity determination
antigen-coated
microplate wells
Details
ELISACytomegalovirus (CMV) p52
incl. IgG/RF absorbent
antigen-coated
microplate wells
Details
ELISACytomegalovirus
(CMV) gB
antigen-coated
microplate wells
Details
ELISACSQ pair of controls
anti-Cytomegalovirus (IgG)
Details
ELISACytomegalovirus (CMV)
antibody determination in CSF
antigen-coated
microplate wells
Details
ELISAVaricella zoster virus
(VZV)
antigen-coated
microplate wells
Details
IIFTVaricella zoster virus
(VZV)
infected cellsEU 168Details
ELISAVaricella zoster virus
(VZV)
antigen-coated
microplate wells
Details
ELISAVaricella zoster virus (VZV)
incl. IgG/RF absorbent
antigen-coated
microplate wells
Details
ELISAVaricella zoster virus (VZV)
avidity determination
antigen-coated
microplate wells
Details
ELISAVaricella zoster virus (VZV)
avidity determination
antigen-coated
microplate wells
Details
ELISAVaricella zoster virus (VZV) glycoprotein
incl. IgG/RF absorbent
antigen-coated
microplate wells
Details
ELISACSQ pair of controls
anti-VZV (IgG)
Details
ELISAVaricella zoster virus (VZV)
antibody determination in CSF
antigen-coated
microplate wells
Details
ELISAVaricella zoster virus (VZV)
antibody determination in CSF
antigen-coated
microplate wells
Details
WESTERNBLOTantibodies against Epstein-Barr virus (EBV)
IgG positive control
Details
WESTERNBLOTantibodies against Epstein-Barr virus (EBV)
IgM positive control
Details
WESTERNBLOTEUROLINE-WB Epstein Barr virus
(EBV)
Details
EUROLINEpositive control serum: IgG, human, 50x concentrated
for EBV-Profil 2 G
Details
EUROLINEpositive control serum: IgM, human, 50x concentrated
for EBV-Profil 2 M
Details
EUROLINEEBV Profile 2
(VCA gp125, VCA p19,
EBNA-1, p22, EA-D separately)
EUROLINEDetails
ChLIAEpstein-Barr virus capsid antigen
(EBV-CA)
Details
ChLIAEpstein-Barr virus capsid antigen
(EBV-CA)
Details
ChLIAControl set
Epstein-Barr virus capsid antigen (EBV-CA)
Details
IIFTEpstein-Barr
virus capsid antigen
(EBV-CA)
Details
IIFTexpressing cellsP3HR1Details
IIFTEpstein-Barr
virus capsid antigen
(EBV-CA) EUROPattern
expressing cellsP3HR1Details
ELISAEpstein-Barr virus capsid antigen
(EBV-CA)
antigen-coated
microplate wells
Details
ELISAEpstein-Barr virus capsid antigen
(EBV-CA)
antigen-coated
microplate wells
Details
ELISAEpstein-Barr virus capsid antigen
(EBV-CA) incl. IgG/RF absorbent
antigen-coated
microplate wells
Details
ELISAEpstein-Barr virus capsid antigen
(EBV-CA) avidity determination
antigen-coated
microplate wells
Details
IIFTEBV capsid antigen (EBV-CA)
EBV early antigen (EBV-EA)
expressing cells
(2 BIOCHIPs per field)
P3HR1
EU 33
Details
ELISACSQ pair of controls
anti-EBV-CA (IgG)
Details
ELISAEpstein-Barr virus capsid antigen
(EBV-CA) antibody determination in CSF
antigen-coated
microplate wells
Details
ChLIAEpstein-Barr virus nuclear antigen 1
(EBNA-1)
Details
ChLIAControl set
Epstein-Barr virus nuclear antigen 1 (EBNA-1)
Details
IIFTEpstein-Barr virus nuclear antigen
(EBNA) EUROPattern
expressing cellsRajiDetails
IIFTEpstein-Barr virus
nuclear antigen (EBNA,
complement-fixing antibodies)
expressing cellsRajiDetails
ELISAEpstein-Barr virus nuclear antigen
(EBNA-1)
antigen-coated
microplate wells
Details
IIFTEpstein-Barr
virus early antigen
(EBV-EA)
expressing cellsEU 33Details
IIFTEpstein-Barr
virus early antigen
(EBV-EA) EUROPattern
expressing cellsEU 33Details
ELISAEpstein-Barr virus early antigen
(EBV-EA)
antigen-coated
microplate wells
Details
ELISAEpstein-Barr virus early antigen
(EBV-EA)
antigen-coated
microplate wells
Details
ELISAEpstein-Barr virus early antigen
(EBV-EA) incl. IgG/RF absorbent
antigen-coated
microplate wells
Details
IIFTBIOCHIP
Sequence EBV
fields A and B: EBV-CA (IgG)
field C: EBV-CA (IgM)
field D: EBV-EA
field E: EBNA


expressing cells
expressing cells
expressing cells
expressing cells


P3HR1
P3HR1
EU 33
Raji
Details
IIFTEUROPLUS
BIOCHIP Sequence EBV
field A: EBV-CA (IgG), gp125 ag, p19 ag

field B: EBV-CA (IgG)
field C: EBV-CA (IgM), gp125 ag, p19 ag

field D: EBV-EA
field E: EBNA


expr. cells, gp125/p19/
ag-free BIOCHIP
expressing cells
expressing cells
expr. cells, gp125/p19/
ag-free BIOCHIP
expressing cells


P3HR1, native/rec.
EU 120
P3HR1
P3HR1, native/rec.
EU 120
EU 33
Raji
Details